(Q63185439)
Statements
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice (English)
Paolo Longoni
Marco Milanesi
Raffaella Milani
Matteo Carrabba
Franca Formelli
Alessandro M Gianni